| 1 | Implications of the Hybrid Epithelial/Mesenchymal Phenotype… (10.3389/fonc.2015.00155) | Abstract References ORCID License | 278.39 | 607 |
| 2 | Radiation-induced brain injury: A review (10.3389/fonc.2012.00073) | Abstract References ORCID License | 273.16 | 538 |
| 3 | Trastuzumab: Updated Mechanisms of Action and Resistance in… (10.3389/fonc.2012.00062) | Abstract References ORCID License | 262.84 | 424 |
| 4 | Mitochondrial Dysfunction in Cancer (10.3389/fonc.2013.00292) | Abstract References ORCID License | 258.88 | 387 |
| 5 | Getting to Know Ovarian Cancer Ascites: Opportunities for Ta… (10.3389/fonc.2013.00256) | Abstract References ORCID License | 256.47 | 366 |
| 6 | The Keap1–Nrf2 system in cancers: stress response and anabol… (10.3389/fonc.2012.00200) | Abstract References ORCID License | 251.32 | 325 |
| 7 | Altered Tumor-Cell Glycosylation Promotes Metastasis (10.3389/fonc.2014.00028) | Abstract References ORCID License | 248.43 | 304 |
| 8 | Vascular Permeability and Drug Delivery in Cancers (10.3389/fonc.2013.00211) | Abstract References ORCID License | 247.57 | 298 |
| 9 | Oxidative Stress and Programmed Cell Death in Yeast (10.3389/fonc.2012.00064) | Abstract References ORCID License | 240.48 | 253 |
| 10 | Histone Ubiquitination and Deubiquitination in Transcription… (10.3389/fonc.2012.00026) | Abstract References ORCID License | 239.27 | 246 |
| 11 | Diffuse intrinsic pontine glioma: poised for progress (10.3389/fonc.2012.00205) | Abstract References ORCID License | 238.92 | 244 |
| 12 | Radiation as an immunological adjuvant: current evidence on… (10.3389/fonc.2012.00153) | Abstract References ORCID License | 237.84 | 238 |
| 13 | Targeting Nuclear Factor-Kappa B to Overcome Resistance to C… (10.3389/fonc.2013.00120) | Abstract References ORCID License | 236.55 | 231 |
| 14 | DNA Double-Strand Break Repair as Determinant of Cellular Ra… (10.3389/fonc.2013.00113) | Abstract References ORCID License | 236.17 | 229 |
| 15 | Complex Interplay between the P-Glycoprotein Multidrug Efflu… (10.3389/fonc.2014.00041) | Abstract References ORCID License | 235.79 | 227 |
| 16 | The convergence of radiation and immunogenic cell death sign… (10.3389/fonc.2012.00088) | Abstract References ORCID License | 235.22 | 224 |
| 17 | Beyond DNA Repair: Additional Functions of PARP-1 in Cancer (10.3389/fonc.2013.00290) | Abstract References ORCID License | 233.24 | 214 |
| 18 | Pyruvate dehydrogenase kinase as a novel therapeutic target… (10.3389/fonc.2013.00038) | Abstract References ORCID License | 232.63 | 211 |
| 19 | Targeting PI3K/Akt/mTOR Signaling in Cancer (10.3389/fonc.2014.00064) | Abstract ORCID License | 232.45 | 1256 |
| 20 | Radiation-induced effects and the immune system in cancer (10.3389/fonc.2012.00191) | Abstract References ORCID License | 229.23 | 195 |
| 21 | Tumor Targeting via Integrin Ligands (10.3389/fonc.2013.00222) | Abstract References ORCID License | 229.23 | 195 |
| 22 | The eEF1A Proteins: At the Crossroads of Oncogenesis, Apopto… (10.3389/fonc.2015.00075) | Abstract References ORCID License | 227.65 | 188 |
| 23 | Unmet support service needs and health-related quality of li… (10.3389/fonc.2013.00075) | Abstract References ORCID License | 225.53 | 179 |
| 24 | Tumor-Penetrating Peptides (10.3389/fonc.2013.00216) | Abstract References ORCID License | 225.29 | 178 |
| 25 | Computational and Experimental Models of Cancer Cell Respons… (10.3389/fonc.2013.00044) | Abstract References ORCID License | 224.55 | 175 |
| 26 | The Potential and Hurdles of Targeted Alpha Therapy – Clinic… (10.3389/fonc.2013.00324) | Abstract References ORCID License | 222.79 | 168 |
| 27 | HERV-K(HML-2), the Best Preserved Family of HERVs: Endogeniz… (10.3389/fonc.2013.00246) | Abstract References ORCID License | 222.27 | 166 |
| 28 | Cellular Potts Modeling of Tumor Growth, Tumor Invasion, and… (10.3389/fonc.2013.00087) | Abstract References ORCID License | 221.48 | 163 |
| 29 | Human Rhabdomyosarcoma Cell Lines for Rhabdomyosarcoma Resea… (10.3389/fonc.2013.00183) | Abstract References ORCID License | 221.48 | 163 |
| 30 | Glycogen Synthesis is Induced in Hypoxia by the Hypoxia-Indu… (10.3389/fonc.2012.00018) | Abstract References ORCID License | 221.22 | 162 |
| 31 | Irradiation Promotes an M2 Macrophage Phenotype in Tumor Hyp… (10.3389/fonc.2012.00089) | Abstract References ORCID License | 220.68 | 160 |
| 32 | The emerging role of fumarate as an oncometabolite (10.3389/fonc.2012.00085) | Abstract References ORCID License | 220.41 | 159 |
| 33 | The interplay between autophagy and ROS in tumorigenesis (10.3389/fonc.2012.00171) | Abstract References ORCID License | 220.14 | 158 |
| 34 | The Notch ligand Jagged1 as a target for anti-tumor therapy (10.3389/fonc.2014.00254) | Abstract References ORCID License | 219.87 | 157 |
| 35 | Current Evidence Linking Polyunsaturated Fatty Acids with Ca… (10.3389/fonc.2013.00224) | Abstract References ORCID License | 219.31 | 155 |
| 36 | Dying cell clearance and its impact on the outcome of tumor… (10.3389/fonc.2012.00116) | Abstract References ORCID License | 218.75 | 153 |
| 37 | Immune Infiltration and Prostate Cancer (10.3389/fonc.2015.00128) | Abstract References ORCID License | 218.75 | 153 |
| 38 | Atypical Teratoid Rhabdoid Tumor: Current Therapy and Future… (10.3389/fonc.2012.00114) | Abstract References ORCID License | 217.03 | 147 |
| 39 | Differential Roles of PML Isoforms (10.3389/fonc.2013.00125) | Abstract References ORCID License | 216.73 | 146 |
| 40 | The Genomic and Proteomic Content of Cancer Cell-Derived Exo… (10.3389/fonc.2012.00038) | Abstract References ORCID License | 216.44 | 145 |
| 41 | Strategies to Increase Drug Penetration in Solid Tumors (10.3389/fonc.2013.00193) | Abstract References ORCID License | 216.44 | 145 |
| 42 | Peptide Hydrogels – Versatile Matrices for 3D Cell Culture i… (10.3389/fonc.2015.00092) | Abstract References ORCID License | 216.14 | 144 |
| 43 | Pediatric High Grade Glioma: a Review and Update on Tumor Cl… (10.3389/fonc.2012.00105) | Abstract References ORCID License | 215.84 | 143 |
| 44 | The Human Cathelicidin Antimicrobial Peptide LL-37 and Mimic… (10.3389/fonc.2015.00144) | Abstract References ORCID License | 215.84 | 143 |
| 45 | Immunosuppressive Mechanisms of Malignant Gliomas: Parallels… (10.3389/fonc.2015.00153) | Abstract References ORCID License | 215.84 | 143 |
| 46 | The Proline Regulatory Axis and Cancer (10.3389/fonc.2012.00060) | Abstract References ORCID License | 214.30 | 138 |
| 47 | Structural Implications for Selective Targeting of PARPs (10.3389/fonc.2013.00301) | Abstract References ORCID License | 213.99 | 137 |
| 48 | VDAC1: from structure to cancer therapy (10.3389/fonc.2012.00164) | Abstract References ORCID License | 213.35 | 135 |
| 49 | Ways to Enhance Lymphocyte Trafficking into Tumors and Fitne… (10.3389/fonc.2013.00231) | Abstract References ORCID License | 213.35 | 135 |
| 50 | Radiation, Inflammation, and Immune Responses in Cancer (10.3389/fonc.2012.00058) | Abstract References ORCID License | 211.39 | 129 |